Poate AI genera regimuri chimioterapice personalizate prin analiza imaginilor microambientului tumoral ?

Eficacitatea tratamentului împotriva cancerului depinde de interacțiuni complexe între tumori și țesuturile înconjurătoare. Inteligența artificială poate procesa imagini de înaltă rezoluție ale microambientelor tumorale pentru a identifica ținte terapeutice. Modelele de învățare automată ar putea prezice care medicamente chimioterapice ar fi cele mai eficiente pentru fiecare pacient în parte. Această abordare își propune să depășească protocoalele de tratament universale. Vor fi necesare studii clinice pentru a valida aceste regimuri generate de AI.

Background

Cancer treatment effectiveness depends on complex interactions between tumors and their surrounding tissues. AI can process high-resolution images of tumor microenvironments to identify therapeutic targets. Machine learning models could predict which chemotherapy drugs would be most effective for individual patients. This approach aims to move beyond one-size-fits-all treatment protocols. Clinical trials would be needed to validate these AI-generated regimens.

Today’s AI excels at detecting patterns in high-resolution histopathology images but does not autonomously design chemotherapy regimens; instead, it supports oncologists by predicting tumor subtypes, immune infiltration levels, or therapy response from microenvironment images. Cutting-edge pipelines combine deep-learning segmentation with multiparametric data (e.g., spatial transcriptomics) to score features like PD-L1 density or TLS maturity, which can be entered into clinical decision-support tools to suggest matching immunotherapies or combinations. However, AI outputs remain probabilistic and require prospective clinical trials before being used to choose cytotoxic drugs or dosing schedules. Regulatory frameworks for such “AI-informed prescribing” are still evolving.

— Enriched May 12, 2026 · Source: National Academies of Sciences, Engineering, and Medicine